Skip to content
drillr.ai
Sign up

APRE

Aprea Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.49
−8.22%
Ask drillr

  • Oct 16, 2026, 12:30 UTC

    Aprea Therapeutics announced that it will host a virtual panel discussion on WEE1 inhibition in precision oncology on October 20, 2026, at 11 a.m. ET.

    Source:

  • Aug 12, 2026, 12:30 UTC

    Aprea Therapeutics announced its financial results for the second quarter of 2026.

    Source: